T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHYF
2076
DELISTED
The Shyft Group
SHYF
| $372K | ﹤0.01% |
59,400
+23,300
| +65% | +$129K |
|
2077
Korn Ferry
KFY
$4.36B
| $369K | ﹤0.01% |
17,830
| – | – |
|
2078
Caleres
CAL
$461M
| $367K | ﹤0.01% |
15,140
| – | – |
|
2079
Coca-Cola Europacific Partners
CCEP
$47.5B
| $366K | ﹤0.01% |
10,250
-3,041,176
| -100% | -$143M |
|
|
OME
2080
DELISTED
Omega Protein
OME
| $365K | ﹤0.01% |
18,260
+3,900
| +27% | +$72.8K |
|
|
SCS
2081
DELISTED
Steelcase
SCS
| $364K | ﹤0.01% |
26,859
| – | – |
|
2082
StoneX
SNEX
$8.05B
| $363K | ﹤0.01% |
67,352
| – | – |
|
|
MOBL
2083
DELISTED
MobileIron, Inc.
MOBL
| $363K | ﹤0.01% |
118,885
-13,117
| -10% | -$47.1K |
|
2084
Piper Sandler
PIPR
$5.54B
| $362K | ﹤0.01% |
38,360
| – | – |
|
|
NP
2085
DELISTED
Neenah, Inc. Common Stock
NP
| $361K | ﹤0.01% |
4,994
-2,600
| -34% | -$175K |
|
2086
TFS Financial
TFSL
$4.93B
| $359K | ﹤0.01% |
20,831
-22
| -0.1% | -$392 |
|
2087
Genesco
GCO
$394M
| $358K | ﹤0.01% |
5,560
| – | – |
|
2088
Alaunos Therapeutics
TCRT
$4.86M
| $358K | ﹤0.01% |
435
+86
| +25% | +$93.6K |
|
2089
Southside Bancshares
SBSI
$984M
| $356K | ﹤0.01% |
11,797
-1
| -0% | -$27 |
|
|
ASNA
2090
DELISTED
Ascena Retail Group, Inc.
ASNA
| $356K | ﹤0.01% |
2,547
-6,828
| -73% | -$1.11M |
|
2091
M/I Homes
MHO
$3.9B
| $353K | ﹤0.01% |
18,744
-26
| -0.1% | -$490 |
|
2092
STAG Industrial
STAG
$7.12B
| $352K | ﹤0.01% |
14,778
+800
| +6% | +$17K |
|
|
PNK
2093
DELISTED
Pinnacle Entertainment Inc.
PNK
| $352K | ﹤0.01% |
31,760
| – | – |
|
2094
Forrester Research
FORR
$224M
| $351K | ﹤0.01% |
9,530
| – | – |
|
|
BKMU
2095
DELISTED
Bank Mutual Corp
BKMU
| $351K | ﹤0.01% |
45,661
| – | – |
|
2096
Rayonier Advanced Materials
RYAM
$570M
| $350K | ﹤0.01% |
25,746
-35,400
| -58% | -$433K |
|
2097
Paycom
PAYC
$10.1B
| $347K | ﹤0.01% |
+8,037
| New | +$314K |
|
|
SIGM
2098
DELISTED
Sigma Designs Inc
SIGM
| $347K | ﹤0.01% |
54,000
| – | – |
|
|
FFKT
2099
DELISTED
Farmers Capital Bank Corp
FFKT
| $347K | ﹤0.01% |
12,682
+1,801
| +17% | +$49.3K |
|
2100
iShares MSCI Japan ETF
EWJ
$23.2B
| $346K | ﹤0.01% |
7,525
-9,125
| -55% | -$424K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.